作者
- Connor, M. (1)
- Durham^1, S. (1)
- Jaworski, T. (3)
- McElhinney, C. (2)
- Olyaee, M. (1)
- Roeser, K. (2)
- Sarosiek, I. (5)
- Sarosiek, J. (4)
- Skoczylas, T. (2)
- Sostarich, S. (5)
|
總筆數:5
| 篇名 | 作者 | 刊名 | 出版年 | 查看 |
|---|
| Rabeprazole augments the mucosal defense by enhancement of the quality ofgastric mucus: its potential clinical significance |
Skoczylas, T.;Sarosiek, I.;Sostarich, S.;McElhinney, C.;Durham^1, S.;Sarosiek, J.; |
The American Journal of Gastroenterology |
2001-09-01 |
查看 |
| Evening vs morning dosing of rabeprazole in gerd patients to controlesophageal acid exposure |
Pehlivanov, N.;Olyaee, M.;Sarosiek, I.;Sostarich, S.;Shea, S.;McCallum, R.; |
The American Journal of Gastroenterology |
2002-09-01 |
查看 |
| Preservation of the protective quality of salivary secretion duringadministration of rabeprazole: its potential clinical relevance |
Skoczylas, T.;Jaworski, T.;Sarosiek, I.;Sostarich, S.;McElhinney, C.;Durham, S.;Sarosiek, J.; |
The American Journal of Gastroenterology |
2002-09-01 |
查看 |
| Profoundly diminished gastric mucus production during Naprosynadministration as a potential factor contributing to mucosal injury |
Jaworski, T.;Sarosiek, I.;Sostarich, S.;Roeser, K.;Sarosiek, J.; |
The American Journal of Gastroenterology |
2003-09-01 |
查看 |
| Restorative impact of rabeprazole on gastric mucus production impairmentduring Naprosyn administration: its potential clinical significance |
Jaworski, T.;Sarosiek, I.;Sostarich, S.;Roeser, K.;Connor, M.;Brotze, S.;Sarosiek, J.; |
The American Journal of Gastroenterology |
2003-09-01 |
查看 |
|
|
|
